GL1X · GenesisL1 explorer

Research workbench

Q9NXZ1: AlphaFold monomer V2.0 prediction for sarcoma antigen 1 (Q9NXZ1)

Analyse Q9NXZ1: AlphaFold monomer V2.0 prediction for sarcoma antigen 1 (Q9NXZ1) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q9NXZ1
Type
protein
Length
904 residues
Chains
1
Deposited
01-JUL-21
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xF971BC1E31DB67C28a8EC14693C86CbCA4944ae3
Molecule
Sarcoma antigen 1
UniProt
Q9NXZ1
Pockets
14 · best druggability 0.80

Structure

1 distinct chain · 8% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASarcoma antigen 1protein9048% helix, 35% strandQ9NXZ1

Pockets

14 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11510.800.9729empty
21170.760.9526empty
31700.750.9240empty
4520.720.9923empty
5590.720.9818empty

Compared structures

  • 8HPP · Crystal structure of human INTS3 with SAGE1 · an experimental structure of the same protein · chain A against C, TM-score 0.09

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.